Saitama, Japan

Kunihiro Niigata


Average Co-Inventor Count = 4.2

ph-index = 8

Forward Citations = 192(Granted Patents)


Location History:

  • Tokyo, JA (1977)
  • Tokyo, JP (1978)
  • Ageo, JP (1978 - 1983)
  • Saitama, JP (1984 - 1997)

Company Filing History:


Years Active: 1977-1997

Loading Chart...
21 patents (USPTO):Explore Patents

Title: Kunihiro Niigata: Innovator Extraordinaire in Pharmaceutical Research

Introduction:

Throughout his illustrious career, Kunihiro Niigata has consistently demonstrated remarkable problem-solving skills and a dedication to innovation. Hailing from Saitama, Japan, Niigata has earned recognition and numerous accolades for his significant contributions to the field of pharmaceutical research. With a total of 21 patents to his name, Niigata continues to push the boundaries of scientific advancement, particularly in the development of hypoglycemic drugs.

Latest Patents:

Among Niigata's most recent patents is the revolutionary "Bisoxadiazolidine derivative - Bisheterocyclic derivative or salt thereof." This patent presents a bisheterocyclic compound, its stereoisomers, tautomers, and pharmaceutically acceptable salts or solvates. The compound, represented by general formula (I), showcases the potential for enhancing insulin sensitivity and thereby serving as an effective hypoglycemic drug.

Career Highlights:

Throughout his career, Niigata has achieved remarkable success and garnered widespread recognition. His exceptional problem-solving skills have led to groundbreaking discoveries in pharmaceutical research. Niigata's ability to analyze and effectively utilize vast amounts of data has been particularly noteworthy, allowing him to develop innovative solutions to complex medical challenges.

Collaborations:

Niigata's expertise and passion for innovation have also led him to collaborate with exceptional professionals in his field. Notably, he has worked alongside Takashi Fujikura and Toichi Takenaka, esteemed researchers who share his drive for advancing pharmaceutical research. These collaborations have fostered an environment of collective creativity and allowed for the exchange of knowledge and ideas.

Conclusion:

Kunihiro Niigata's impressive career in pharmaceutical research is a testament to his exceptional problem-solving skills and innovative mindset. Through his relentless dedication and numerous patents, Niigata has made significant contributions to the development of hypoglycemic drugs and the enhancement of insulin sensitivity. As he continues his journey at Yamanouchi Pharmaceutical Company Ltd., Niigata's work stands as a shining example of the value of innovation and its potential to transform healthcare for the better.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…